Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Johnson & Johnson
< Previous
1
2
3
Next >
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
April 25, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
April 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Dividend Increase of 5.3%
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q1 2023 Results
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
April 04, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
March 08, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 13, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
February 02, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
January 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
January 03, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
December 14, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 13, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 07, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
November 30, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Abiomed
November 01, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
ABMD
JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2022
October 19, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q3 2022 Results
October 18, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
October 03, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
September 28, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 20, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces $5 Billion Share Repurchase Program
September 14, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 13, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
August 24, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 09, 2022
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.